Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jong, Robert S."'
Autor:
Koopman, Miriam, Antonini, Ninja F, Douma, Joep, Wals, Jaap, Honkoop, Aafke H, Erdkamp, Frans LG, de Jong, Robert S, Rodenburg, Cees J, Vreugdenhil, Gerard, Loosveld, Olaf JL, van Bochove, Aart, Sinnige, Harm AM, Creemers, Geert-Jan M, Tesselaar, Margot ET, Slee, Peter H Th J, Werter, Marjon JBP, Mol, Linda, Dalesio, Otilia, Punt, Cornelis JA
Publikováno v:
In The Lancet 14-20 July 2007 370(9582):135-142
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Meulendijks, Didier, De Groot, Jan Willem B, Los, Maartje, Boers, James E., Beerepoot, Laurens V., Polee, Marco B., Beeker, Aart, Portielje, Johanna E A, Goey, Swan H., De Jong, Robert S., Vanhoutvin, Steven A L W, Kuiper, Maria, Sikorska, Karolina, Pluim, Dick, Beijnen, Jos H., Schellens, Jan H M, Grootscholten, Cecile, Tesselaar, Margot E T, Cats, Annemieke, Sub Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Cancer, 122(9), 1434. John Wiley and Sons Inc.
The current study was a multicenter, single-arm, phase 2 study performed to investigate the feasibility and efficacy of bevacizumab combined with docetaxel, oxaliplatin, and capecitabine (B-DOC) in patients with advanced human epidermal growth factor
Autor:
Meulendijks, Didier, Beerepoot, Laurens V., Boot, Henk, de Groot, Jan Willem B, Los, Maartje, Boers, James E., Vanhoutvin, Steven A L W, Polee, Marco B., Beeker, Aart, Portielje, Johanna E A, de Jong, Robert S., Goey, Swan H., Kuiper, Maria, Sikorska, Karolina, Beijnen, Jos H., Tesselaar, Margot E., Schellens, Jan H M, Cats, Annemieke
Summary: Objective To investigate the efficacy of bevacizumab and trastuzumab combined with docetaxel, oxaliplatin, and capecitabine (B-DOCT) as first-line treatment of advanced human epidermal growth factor receptor 2 (HER2)-positive gastric cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::249ed98d1dbd435c83166eb0257c2704
https://dspace.library.uu.nl/handle/1874/330130
https://dspace.library.uu.nl/handle/1874/330130
Autor:
van Staveren, Maurice C., van Kuilenburg, Andre B. P., Guchelaar, Henk-Jan, Meijer, Judith, Punt, Cornelis J. A., de Jong, Robert S., Gelderblom, Hans, Maring, Jan Gerard
Publikováno v:
British journal of clinical pharmacology, 81(3), 553-561. Wiley-Blackwell
Dihydropyrimidine dehydrogenase (DPD) deficiency can lead to severe toxicity following 5-fluorouracil (5FU) or capecitabine (CAP) treatment. Uracil (U) can be used as a probe to determine systemic DPD activity. The present study was performed to asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1b9626888cf485f4f448ebd2b1197027
https://europepmc.org/articles/PMC4767209/
https://europepmc.org/articles/PMC4767209/
Autor:
Staveren, Maurice C., Kuilenburg, Andre B. P., Guchelaar, Henk‐Jan, Meijer, Judith, Punt, Cornelis J. A., Jong, Robert S., Gelderblom, Hans, Maring, Jan Gerard
Publikováno v:
British Journal of Clinical Pharmacology; Mar2016, Vol. 81 Issue 3, p553-561, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
de Jong, Robert S., de Vries, Elisabeth G. E., Meijer, Sytze, de Jong, Paul E., Mulder, Nanno H.
Publikováno v:
Cancer Chemotherapy & Pharmacology; Jun1998, Vol. 42 Issue 2, p160-164, 5p
Publikováno v:
In The American Journal of Medicine 2003 114(8):708-709
Autor:
van Staveren MC; Department of Clinical Pharmacy, Treant Healthgroup, Scheper Hospital, Emmen, The Netherlands., van Kuilenburg AB; Laboratory of Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Meijer J; Laboratory of Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., de Jong RS; Department of Oncology, Martini Hospital, Groningen, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, University Hospital of Leiden, Leiden, The Netherlands., Maring JG; Department of Pharmacy, Isala Diaconessen Hospital, Meppel and Bethesda Hospital,Hoogeveen, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Mar; Vol. 81 (3), pp. 553-61. Date of Electronic Publication: 2016 Jan 08.